S&P 500   3,204.54 (-0.68%)
DOW   26,685.39 (-0.69%)
QQQ   257.83 (-1.18%)
AAPL   384.55 (-1.62%)
MSFT   203.94 (-1.97%)
FB   238.68 (-0.67%)
GOOGL   1,503.63 (-0.87%)
AMZN   2,987.00 (-0.73%)
NVDA   403.06 (-1.47%)
CGC   17.96 (-1.05%)
BABA   243.12 (-2.44%)
MU   49.96 (-1.09%)
GE   7.10 (-0.56%)
TSLA   1,507.82 (-2.47%)
AMD   54.50 (-1.52%)
T   30.31 (+1.00%)
ACB   12.22 (-5.05%)
F   6.80 (+0.89%)
GILD   76.12 (-0.69%)
DIS   119.36 (-1.27%)
NFLX   521.61 (-0.32%)
BAC   24.01 (-2.40%)
BA   180.84 (-3.78%)
S&P 500   3,204.54 (-0.68%)
DOW   26,685.39 (-0.69%)
QQQ   257.83 (-1.18%)
AAPL   384.55 (-1.62%)
MSFT   203.94 (-1.97%)
FB   238.68 (-0.67%)
GOOGL   1,503.63 (-0.87%)
AMZN   2,987.00 (-0.73%)
NVDA   403.06 (-1.47%)
CGC   17.96 (-1.05%)
BABA   243.12 (-2.44%)
MU   49.96 (-1.09%)
GE   7.10 (-0.56%)
TSLA   1,507.82 (-2.47%)
AMD   54.50 (-1.52%)
T   30.31 (+1.00%)
ACB   12.22 (-5.05%)
F   6.80 (+0.89%)
GILD   76.12 (-0.69%)
DIS   119.36 (-1.27%)
NFLX   521.61 (-0.32%)
BAC   24.01 (-2.40%)
BA   180.84 (-3.78%)
S&P 500   3,204.54 (-0.68%)
DOW   26,685.39 (-0.69%)
QQQ   257.83 (-1.18%)
AAPL   384.55 (-1.62%)
MSFT   203.94 (-1.97%)
FB   238.68 (-0.67%)
GOOGL   1,503.63 (-0.87%)
AMZN   2,987.00 (-0.73%)
NVDA   403.06 (-1.47%)
CGC   17.96 (-1.05%)
BABA   243.12 (-2.44%)
MU   49.96 (-1.09%)
GE   7.10 (-0.56%)
TSLA   1,507.82 (-2.47%)
AMD   54.50 (-1.52%)
T   30.31 (+1.00%)
ACB   12.22 (-5.05%)
F   6.80 (+0.89%)
GILD   76.12 (-0.69%)
DIS   119.36 (-1.27%)
NFLX   521.61 (-0.32%)
BAC   24.01 (-2.40%)
BA   180.84 (-3.78%)
S&P 500   3,204.54 (-0.68%)
DOW   26,685.39 (-0.69%)
QQQ   257.83 (-1.18%)
AAPL   384.55 (-1.62%)
MSFT   203.94 (-1.97%)
FB   238.68 (-0.67%)
GOOGL   1,503.63 (-0.87%)
AMZN   2,987.00 (-0.73%)
NVDA   403.06 (-1.47%)
CGC   17.96 (-1.05%)
BABA   243.12 (-2.44%)
MU   49.96 (-1.09%)
GE   7.10 (-0.56%)
TSLA   1,507.82 (-2.47%)
AMD   54.50 (-1.52%)
T   30.31 (+1.00%)
ACB   12.22 (-5.05%)
F   6.80 (+0.89%)
GILD   76.12 (-0.69%)
DIS   119.36 (-1.27%)
NFLX   521.61 (-0.32%)
BAC   24.01 (-2.40%)
BA   180.84 (-3.78%)
Log in

NASDAQ:CTRECaretrust REIT Stock Price, Forecast & News

$16.52
-0.27 (-1.61 %)
(As of 07/16/2020 01:03 PM ET)
Add
Compare
Today's Range
$16.51
Now: $16.52
$16.73
50-Day Range
$16.32
MA: $18.23
$20.85
52-Week Range
$7.16
Now: $16.52
$24.56
Volume9,510 shs
Average Volume1.30 million shs
Market Capitalization$1.58 billion
P/E Ratio31.77
Dividend Yield6.05%
Beta1.03
CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition and leasing of seniors housing and healthcare-related properties. With 199 net-leased healthcare properties and three operated seniors housing properties in 27 states, CareTrust is pursuing opportunities across the nation to acquire properties that will be leased to a diverse group of local, regional and national seniors housing operators, healthcare services providers, and other healthcare-related businesses.
Read More
Caretrust REIT logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.15 out of 5 stars


Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustryN/A
SectorFinance
Current SymbolNASDAQ:CTRE
Previous SymbolNASDAQ:CTREV
CUSIPN/A
Phone949-542-3130

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$163.40 million
Cash Flow$1.09 per share
Book Value$9.71 per share

Profitability

Net Income$46.36 million

Miscellaneous

Employees57
Market Cap$1.58 billion
Next Earnings Date8/4/2020 (Estimated)
OptionableOptionable

Receive CTRE News and Ratings via Email

Sign-up to receive the latest news and ratings for CTRE and its competitors with MarketBeat's FREE daily newsletter.

Caretrust REIT (NASDAQ:CTRE) Frequently Asked Questions

How has Caretrust REIT's stock been impacted by COVID-19 (Coronavirus)?

Caretrust REIT's stock was trading at $16.99 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CTRE stock has decreased by 2.8% and is now trading at $16.52. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Caretrust REIT?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Caretrust REIT in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Caretrust REIT.

When is Caretrust REIT's next earnings date?

Caretrust REIT is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Caretrust REIT.

How were Caretrust REIT's earnings last quarter?

Caretrust REIT Inc (NASDAQ:CTRE) released its quarterly earnings data on Thursday, May, 7th. The real estate investment trust reported $0.20 EPS for the quarter, missing analysts' consensus estimates of $0.34 by $0.14. The real estate investment trust had revenue of $44.34 million for the quarter, compared to analysts' expectations of $43.20 million. Caretrust REIT had a net margin of 29.53% and a return on equity of 5.32%. View Caretrust REIT's earnings history.

How often does Caretrust REIT pay dividends? What is the dividend yield for Caretrust REIT?

Caretrust REIT announced a quarterly dividend on Wednesday, June 17th. Investors of record on Tuesday, June 30th will be paid a dividend of $0.25 per share on Wednesday, July 15th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 6.05%. The ex-dividend date is Monday, June 29th. View Caretrust REIT's dividend history.

What guidance has Caretrust REIT issued on next quarter's earnings?

Caretrust REIT updated its FY 2020 After-Hours earnings guidance on Thursday, May, 7th. The company provided EPS guidance of 1.32-1.34 for the period.

What price target have analysts set for CTRE?

7 brokerages have issued 12 month target prices for Caretrust REIT's stock. Their forecasts range from $13.00 to $26.00. On average, they anticipate Caretrust REIT's stock price to reach $21.43 in the next year. This suggests a possible upside of 29.7% from the stock's current price. View analysts' price targets for Caretrust REIT.

Has Caretrust REIT been receiving favorable news coverage?

News articles about CTRE stock have been trending positive on Thursday, according to InfoTrie. The research group ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Caretrust REIT earned a coverage optimism score of 2.1 on InfoTrie's scale. They also gave news coverage about the real estate investment trust a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the near future. View the latest news about Caretrust REIT.

Are investors shorting Caretrust REIT?

Caretrust REIT saw a decrease in short interest in the month of June. As of June 30th, there was short interest totaling 1,790,000 shares, a decrease of 16.4% from the June 15th total of 2,140,000 shares. Based on an average trading volume of 865,200 shares, the days-to-cover ratio is currently 2.1 days. Currently, 1.9% of the company's stock are short sold. View Caretrust REIT's Current Options Chain.

Who are some of Caretrust REIT's key competitors?

What other stocks do shareholders of Caretrust REIT own?

Who are Caretrust REIT's key executives?

Caretrust REIT's management team includes the following people:
  • Mr. Gregory K. Stapley J.D., Chairman, Pres & CEO (Age 59)
  • Mr. William M. Wagner, CFO, Treasurer & Sec. (Age 53)
  • Mr. David M. Sedgwick, Chief Operating Officer (Age 43)
  • Mr. Mark D. Lamb, Chief Investment Officer
  • Ms. Lauren Beale, Controller

What is Caretrust REIT's stock symbol?

Caretrust REIT trades on the NASDAQ under the ticker symbol "CTRE."

Who are Caretrust REIT's major shareholders?

Caretrust REIT's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Scout Investments Inc. (0.22%), State of Alaska Department of Revenue (0.12%), Envestnet Asset Management Inc. (0.01%) and Exane Derivatives (0.01%). View institutional ownership trends for Caretrust REIT.

Which institutional investors are selling Caretrust REIT stock?

CTRE stock was sold by a variety of institutional investors in the last quarter, including Scout Investments Inc., and Envestnet Asset Management Inc.. View insider buying and selling activity for Caretrust REIT.

Which institutional investors are buying Caretrust REIT stock?

CTRE stock was bought by a variety of institutional investors in the last quarter, including Exane Derivatives, and State of Alaska Department of Revenue. View insider buying and selling activity for Caretrust REIT.

How do I buy shares of Caretrust REIT?

Shares of CTRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Caretrust REIT's stock price today?

One share of CTRE stock can currently be purchased for approximately $16.52.

How big of a company is Caretrust REIT?

Caretrust REIT has a market capitalization of $1.58 billion and generates $163.40 million in revenue each year. The real estate investment trust earns $46.36 million in net income (profit) each year or $1.36 on an earnings per share basis. Caretrust REIT employs 57 workers across the globe.

What is Caretrust REIT's official website?

The official website for Caretrust REIT is www.caretrustreit.com.

How can I contact Caretrust REIT?

Caretrust REIT's mailing address is 905 CALLE AMANECER SUITE 300, SAN CLEMENTE CA, 92673. The real estate investment trust can be reached via phone at 949-542-3130 or via email at [email protected]

This page was last updated on 7/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.